Dihua Yu Department of Molecular and Cellular Oncology The University of Texas MD Anderson Cancer Center Biography Publications Institution JoVE Articles Dihua Yu has not added a biography. If you are Dihua Yu and would like to personalize this page please email our Author Liaison for assistance. Publications Brain Metastasis: Unique Challenges and Open Opportunities Biochimica Et Biophysica Acta. Jan, 2017 | Pubmed ID: 27939792 Advances in Decoding Breast Cancer Brain Metastasis Cancer Metastasis Reviews. Dec, 2016 | Pubmed ID: 27873078 Deubiquitination and Stabilization of PD-L1 by CSN5 Cancer Cell. Dec, 2016 | Pubmed ID: 27866850 Glycosylation and Stabilization of Programmed Death Ligand-1 Suppresses T-cell Activity Nature Communications. Aug, 2016 | Pubmed ID: 27572267 Downregulation of GLUT4 Contributes to Effective Intervention of Estrogen Receptor-negative/HER2-overexpressing Early Stage Breast Disease Progression by Lapatinib American Journal of Cancer Research. 2016 | Pubmed ID: 27293993 Upregulation of Lactate Dehydrogenase a by 14-3-3ζ Leads to Increased Glycolysis Critical for Breast Cancer Initiation and Progression Oncotarget. Jun, 2016 | Pubmed ID: 27150057 Selective Expression of Constitutively Active Pro-apoptotic Protein BikDD Gene in Primary Mammary Tumors Inhibits Tumor Growth and Reduces Tumor Initiating Cells American Journal of Cancer Research. 2015 | Pubmed ID: 26885451 Fluoxetine Induces Cytotoxic Endoplasmic Reticulum Stress and Autophagy in Triple Negative Breast Cancer World Journal of Clinical Oncology. Dec, 2015 | Pubmed ID: 26677444 Microenvironment-induced PTEN Loss by Exosomal MicroRNA Primes Brain Metastasis Outgrowth Nature. Nov, 2015 | Pubmed ID: 26479035 Src Inhibition Blocks C-Myc Translation and Glucose Metabolism to Prevent the Development of Breast Cancer Cancer Research. Sep, 2015 | Pubmed ID: 26383165 Neural Stem Cells Secreting Anti-HER2 Antibody Improve Survival in a Preclinical Model of HER2 Overexpressing Breast Cancer Brain Metastases Stem Cells (Dayton, Ohio). Oct, 2015 | Pubmed ID: 26260958 PI3K-independent MTOR Activation Promotes Lapatinib Resistance and IAP Expression That Can Be Effectively Reversed by MTOR and Hsp90 Inhibition Cancer Biology & Therapy. 2015 | Pubmed ID: 25692408 14-3-3ζ Turns TGF-β's Function from Tumor Suppressor to Metastasis Promoter in Breast Cancer by Contextual Changes of Smad Partners from P53 to Gli2 Cancer Cell. Feb, 2015 | Pubmed ID: 25670079 Heregulin-HER3-HER2 Signaling Promotes Matrix Metalloproteinase-dependent Blood-brain-barrier Transendothelial Migration of Human Breast Cancer Cell Lines Oncotarget. Feb, 2015 | Pubmed ID: 25668816 HER Family Kinase Domain Mutations Promote Tumor Progression and Can Predict Response to Treatment in Human Breast Cancer Molecular Oncology. Mar, 2015 | Pubmed ID: 25435280 S6K1 Promotes Invasiveness of Breast Cancer Cells in a Model of Metastasis of Triple-negative Breast Cancer American Journal of Translational Research. 2014 | Pubmed ID: 25075253 MDM2-mediated Degradation of SIRT6 Phosphorylated by AKT1 Promotes Tumorigenesis and Trastuzumab Resistance in Breast Cancer Science Signaling. Jul, 2014 | Pubmed ID: 25074979 Cooperativity of Oncogenic K-ras and Downregulated P16/INK4A in Human Pancreatic Tumorigenesis PloS One. 2014 | Pubmed ID: 25029561 Definition of PKC-α, CDK6, and MET As Therapeutic Targets in Triple-negative Breast Cancer Cancer Research. Sep, 2014 | Pubmed ID: 24970481 Biomarker-guided Sequential Targeted Therapies to Overcome Therapy Resistance in Rapidly Evolving Highly Aggressive Mammary Tumors Cell Research. May, 2014 | Pubmed ID: 24675532 Enhanced PI3K P110α Signaling Confers Acquired Lapatinib Resistance That Can Be Effectively Reversed by a P110α-selective PI3K Inhibitor Molecular Cancer Therapeutics. Jan, 2014 | Pubmed ID: 24249715 14-3-3ζ Orchestrates Mammary Tumor Onset and Progression Via MiR-221-mediated Cell Proliferation Cancer Research. Jan, 2014 | Pubmed ID: 24197133 Inhibition of Type I Insulin-like Growth Factor Receptor Signaling Attenuates the Development of Breast Cancer Brain Metastasis PloS One. 2013 | Pubmed ID: 24039934 Needle-based Fluorescence Endomicroscopy Via Structured Illumination with a Plastic, Achromatic Objective Journal of Biomedical Optics. Sep, 2013 | Pubmed ID: 24002190 SRC Family Kinases As Novel Therapeutic Targets to Treat Breast Cancer Brain Metastases Cancer Research. Sep, 2013 | Pubmed ID: 23913825 同时针对肿瘤细胞和诱导的 T 细胞反应的淡化,有效地抑制乳腺癌曲妥珠单抗耐药。 Cancer Research. Sep, 2012 | Pubmed ID: 22773664 Growth Factor Signaling in Metastasis: Current Understanding and Future Opportunities Cancer Metastasis Reviews. Dec, 2012 | Pubmed ID: 22706845 The Skp2-SCF E3 Ligase Regulates Akt Ubiquitination, Glycolysis, Herceptin Sensitivity, and Tumorigenesis Cell. May, 2012 | Pubmed ID: 22632973 证据的 GTP 绑定域但不是催化域的转谷氨酰胺 2 是对乳腺上皮细胞中的上皮-间充质过渡十分重要。 Breast Cancer Research : BCR. Jan, 2012 | Pubmed ID: 22225906 靶向抗癌疗法在 Src 家族激酶: 承诺转化为胜利。 Trends in Pharmacological Sciences. Dec, 2011 | Pubmed ID: 22153719 核仁素蛋白与微处理器复杂影响的 Microrna 15a 生源与 16 进行交互。 The Journal of Biological Chemistry. Dec, 2011 | Pubmed ID: 22049078 BikDD 消除了乳腺癌发起的单元格,并淡化与 Lapatinib 治疗乳腺癌。 Cancer Cell. Sep, 2011 | Pubmed ID: 21907925 第一阶段/二研究的曲妥珠单抗结合 Everolimus (RAD001) 患者 HER2 表达的转移性乳腺癌者基于曲妥珠单抗的治疗上取得了进展。 Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. Aug, 2011 | Pubmed ID: 21730275 脑转移瘤的微环境影响因素。 Cell & Bioscience. 2011 | Pubmed ID: 21711688 组织转谷氨酰胺的异常表达促进乳腺上皮细胞中的干细胞特性的证据。 PloS One. 2011 | Pubmed ID: 21687668 飞行员和可行性研究: 前瞻性的蛋白质组学分析从高危妇女乳腺上皮细胞提供证据的 Pro-survival 通路的激活。 Breast Cancer Research and Treatment. Jun, 2011 | Pubmed ID: 21647677 癌症细胞迁移: 综合矩阵力学和改造潜力的角色。 PloS One. 2011 | Pubmed ID: 21647371 针对 SRC,多个电阻通路的下游节点共同打击曲妥珠单抗抵抗。 Nature Medicine. Apr, 2011 | Pubmed ID: 21399647 P53 规管上皮细胞转型与干细胞属性通过调控 Mirna。 Nature Cell Biology. Mar, 2011 | Pubmed ID: 21336307 从肥胖和非肥胖妇女患乳腺癌风险高的乳腺上皮细胞蛋白质芯片分析: 可行性数据。 Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology. Mar, 2011 | Pubmed ID: 21242333 细胞因子受体 CXCR4 介导雌激素独立肿瘤发生、 转移及抗人乳腺癌内分泌治疗。 Cancer Research. Jan, 2011 | Pubmed ID: 21123450 14-3-3Ζ 作为预后标记和癌症的治疗目标。 Expert Opinion on Therapeutic Targets. Dec, 2010 | Pubmed ID: 21058923 P21(CIP1/WAF1) 乳腺上皮细胞的活化加速乳腺肿瘤的发生和促进肺转移。 Biochemical and Biophysical Research Communications. Dec, 2010 | Pubmed ID: 21040707 组织转谷氨酰胺诱导间充质细胞转型乳腺上皮细胞促进耐药和入侵。 PloS One. 2010 | Pubmed ID: 20967228 癌症细胞刚度: 集成三维矩阵刚度和改造潜力的角色。 Biophysical Journal. Oct, 2010 | Pubmed ID: 20923638 乳腺上皮细胞的小鼠双分钟由 Akt 2 激活延迟乳腺退化并加速乳腺肿瘤发生的关系。 Cancer Research. Oct, 2010 | Pubmed ID: 20841468 Pten 基因,PIK3CA,p-AKT,和 P P70S6K 状态: 协会与曲妥珠单抗反应和 HER2 阳性转移性乳腺癌患者的生存。 The American Journal of Pathology. Oct, 2010 | Pubmed ID: 20813970 PI (3) 国王相距 PTEN 的在癌症中的作用。 Clinical Cancer Research : an Official Journal of the American Association for Cancer Research. Sep, 2010 | Pubmed ID: 20622047 乳腺浸润性癌发展:"致命意外"从故障中"电机"和"刹车"。 Cell Cycle (Georgetown, Tex.). Feb, 2010 | Pubmed ID: 20090417 对曲妥珠单抗和 Lapatinib 在乳腺癌组织中的反应的分子预测指标。 Nature Reviews. Clinical Oncology. Feb, 2010 | Pubmed ID: 20027191 中性粒细胞明胶酶相关载脂蛋白由 ErbB2 通过核因子 KappaB 激活表达上调。 Cancer Research. Dec, 2009 | Pubmed ID: 19951994 14-3-3zeta 与 ErbB2 促进导管内原位进展到乳腺浸润性癌癌诱导上皮-间充质细胞转合作。 Cancer Cell. Sep, 2009 | Pubmed ID: 19732720 乳腺癌转移: 挑战和机遇。 Cancer Research. Jun, 2009 | Pubmed ID: 19470768 介导 ErbB2 Src 和信号转导和转录激活因子 3 的导致转录向上-p21Cip1 和乳腺癌细胞化疗耐药的调控。 Molecular Cancer Research : MCR. Apr, 2009 | Pubmed ID: 19372587 14-3-3zeta/tau Heterodimers 规范中迁移的弹弓活动角质形成细胞。 Biochemical and Biophysical Research Communications. Jun, 2009 | Pubmed ID: 19371722 14-3-3zeta 高效表达定义高风险的乳腺癌术后复发并促进肿瘤细胞存活。 Cancer Research. Apr, 2009 | Pubmed ID: 19318578 氧传感器提高了生长因子信号。 Nature Medicine. Mar, 2009 | Pubmed ID: 19265822 有丝分裂放松管制的超量 ErbB2 表达乳腺癌细胞中生存素有助于紫杉醇抗。 Clinical Cancer Research : an Official Journal of the American Association for Cancer Research. Feb, 2009 | Pubmed ID: 19228734 在癌症生物学博士培训。 Cancer Research. Nov, 2008 | Pubmed ID: 19010881 14-3-3 Zeta 向下调节乳腺上皮细胞中的 P53 和赋予鲁米那灌装。 Cancer Research. Mar, 2008 | Pubmed ID: 18339856 ERK 促进肿瘤发生抑制 FOXO3a 通过介导 MDM2 的退化。 Nature Cell Biology. Feb, 2008 | Pubmed ID: 18204439 Trimethylation 在赖氨酸 27 组蛋白 H3 的损失是在乳房、 卵巢、 和胰腺癌预后较差的预测指标。 Molecular Carcinogenesis. Sep, 2008 | Pubmed ID: 18176935 乳腺癌细胞 Chemosensitization 的小说途径: E1A 故事。 Advances in Experimental Medicine and Biology. 2007 | Pubmed ID: 17993239 介导 ErbB2 乳房癌化疗耐药的分子机制。 Advances in Experimental Medicine and Biology. 2007 | Pubmed ID: 17993237 临床前试验临床上适用的战略,以克服曲妥珠单抗耐 Pten 基因缺陷所致。 Clinical Cancer Research : an Official Journal of the American Association for Cancer Research. Oct, 2007 | Pubmed ID: 17908983 Rad51 高效表达有助于人体软组织肉瘤细胞化疗耐药: P53/活化蛋白 2 转录调控的作用。 Molecular Cancer Therapeutics. May, 2007 | Pubmed ID: 17513613 软组织肉瘤 P53 第 4 外显子突变的发生率很高。 Cancer. Jun, 2007 | Pubmed ID: 17429838 肿瘤的形成过程与转移的遗传到微环境的影响因素: 肿瘤进展及转移美国国家卫生研究院研究中的节的荣誉博士马丁 L.Padarathsingh,2006 年 5 月 31 日,乔治敦,华盛顿的一次研讨会。 Cancer Biology & Therapy. Dec, 2006 | Pubmed ID: 17224636 腺病毒载体基于 SiRNA 对作为肺癌基因治疗的前景工具 K-ras 突变体: Kill A 许可证。 Cancer Biology & Therapy. Dec, 2006 | Pubmed ID: 17224631 野生型 P53 抑制核因子活化诱导基质金属蛋白酶 9 启动子激活: 对软组织肉瘤生长和转移的影响。 Molecular Cancer Research : MCR. Nov, 2006 | Pubmed ID: 17077165 细胞质中的 P21CIP1/WAF1 表达是与 IKKbeta 表达对人类乳腺癌相关的。 International Journal of Oncology. Nov, 2006 | Pubmed ID: 17016640 软组织肉瘤细胞血管内皮生长因子过度表达: 对肿瘤生长、 转移及化疗耐药的影响。 Cancer Research. Sep, 2006 | Pubmed ID: 16951193 疾病的机制: 理解抗性人类乳腺癌 HER2 靶向治疗。 Nature Clinical Practice. Oncology. May, 2006 | Pubmed ID: 16683005 选择性抑制的超量 ErbB2 表达乳腺癌患者体内达基于 ErbB2 针对一种新型的信号转导和转录 3 阻止肽活化子。 Cancer Research. Apr, 2006 | Pubmed ID: 16585203 合成三萜 2-cyano-3,12-dioxooleana-1,9-dien-28-oic 酸诱导超量 HER2 表达乳腺癌细胞生长逮捕。 Molecular Cancer Therapeutics. Feb, 2006 | Pubmed ID: 16505105 ErbB2 增加血管内皮生长因子蛋白质合成通过激活哺乳动物的雷帕霉素/p70S6K 导致增加血管生成和人类乳腺癌细胞的自发转移目标。 Cancer Research. Feb, 2006 | Pubmed ID: 16489002 前列腺肿瘤细胞表达被截断的 NS1 蛋白重组流感病毒感染激活溶 CD8 + 细胞识别 Noninfected 的肿瘤细胞。 Journal of Virology. Jan, 2006 | Pubmed ID: 16352563 曲妥珠单抗耐及临床意义的机制。 Annals of the New York Academy of Sciences. Nov, 2005 | Pubmed ID: 16382045 疑难在天之灵吗?: 作为转移抑制 Akt1。 Cancer Cell. Dec, 2005 | Pubmed ID: 16338656 ErbB2 促进 Src 合成和稳定性: Src 激活的赋予乳腺癌转移的新型机制。 Cancer Research. Mar, 2005 | Pubmed ID: 15753384 在肿瘤中的端粒延长替代鲁棒检测显示的肉瘤和星形细胞中的染色体端粒延长替代的意义。 Clinical Cancer Research : an Official Journal of the American Association for Cancer Research. Jan, 2005 | Pubmed ID: 15671549 受体酪氨酸激酶表皮生长因子受体和表皮-2/纽在滑膜肉瘤中的表达。 Cancer. Feb, 2005 | Pubmed ID: 15641030 由野生型 P53 蛋白激酶 Calpha Sp1 通过转录抑制参与多药耐药 1 P-糖蛋白磷酸化的抑制作用。 The Journal of Biological Chemistry. Feb, 2005 | Pubmed ID: 15563462 CXCR4 上调是 HER2 介导肿瘤转移的必要条件。 Cancer Cell. Nov, 2004 | Pubmed ID: 15542430 激活 Akt 和哺乳动物的雷帕霉素/4E-BP1 通路 ErbB2 过表达的目标预测乳腺癌肿瘤进展。 Clinical Cancer Research : an Official Journal of the American Association for Cancer Research. Oct, 2004 | Pubmed ID: 15501954 有助于肿瘤抑制由曲妥珠单抗,pten 基因激活和抑癌基因 Pten 的损失预测曲妥珠单抗耐药的。 Cancer Cell. Aug, 2004 | Pubmed ID: 15324695 肌醇: 错义突变激发恶性肿瘤。 Cancer Biology & Therapy. Aug, 2004 | Pubmed ID: 15280668 沿袭失真的丙二醛-MB-435 细胞: 乳腺癌细胞中的黑素细胞蛋白的表达。 Cancer Research. May, 2004 | Pubmed ID: 15150101 Liposomal 介导 ErbB2 反义 DNA 的转移: 在抗癌战争时代的来临。 Cancer Biology & Therapy. Feb, 2004 | Pubmed ID: 14764991 水飞蓟宾: 棘手的表皮生长因子-R 表示肿瘤治疗吗? Cancer Biology & Therapy. Sep-Oct, 2003 | Pubmed ID: 14614321 联合曲妥珠单抗和紫杉醇治疗更好地抑制 ErbB 2 介导乳腺癌通过 Akt 比独自哪种治疗更有效抑制血管生成。 Cancer. Oct, 2003 | Pubmed ID: 14508823 在人乳腺癌中的 ErbB2 过表达与 P34Cdc2 P21Cip1 上调和酪氨酸 15 Hyperphosphorylation 相关: 酰胺,甲氨蝶呤和 5-氟尿嘧啶化疗差响应是关联与 Erb2 表达和 P21Cip1 表达。 Cancer. Sep, 2003 | Pubmed ID: 12973835 紫杉醇诱导细胞凋亡赫赛汀预处理中 ErbB2 超量表达乳腺癌细胞的强化的宣传。 Cancer Research. Oct, 2002 | Pubmed ID: 12384528 11 人类肉瘤细胞株的表征: 评价的细胞遗传学、 致瘤性、 转移及血管生成因子的生产。 Cancer. Oct, 2002 | Pubmed ID: 12237927 ErbB2 过表达与血管内皮生长因子的 A、 C 和 D 在人乳腺癌中的表达增加相关。 Cancer. Jun, 2002 | Pubmed ID: 12115372 P34(Cdc2) 由 ErbB2 酪氨酸 15 日磷酸化抑制 P34(Cdc2) 激活并参与紫杉醇诱导细胞凋亡抗性。 Molecular Cell. May, 2002 | Pubmed ID: 12049736 组合 Anti-fetal 肝激酶 1 单克隆抗体和连续低剂量阿霉素诱导的内皮细胞凋亡抑制血管生成和人体软组织肉瘤移植瘤的生长。 Cancer Research. Apr, 2002 | Pubmed ID: 11929822 早期胎盘胰岛素样生长因子 (pro 癫痫) 是外域和具有高入侵潜力 C ErbB 2 阳性细胞分泌的。 Cancer Research. Feb, 2002 | Pubmed ID: 11861376 颈动脉肿瘤细胞注射,产生脑转移瘤小鼠模型 Chenyu Zhang1, Frank J. Lowery1, Dihua Yu1 1Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center JoVE 55085 Cancer Research 高分辨率光纤内窥镜为原位细胞成像 Mark Pierce1, Dihua Yu2, Rebecca Richards-Kortum1 1Department of Bioengineering, Rice University, 2Department of Molecular and Cellular Oncology, The Univeristy of Texas M. D. Anderson Cancer Center JoVE 2306 Bioengineering
颈动脉肿瘤细胞注射,产生脑转移瘤小鼠模型 Chenyu Zhang1, Frank J. Lowery1, Dihua Yu1 1Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center JoVE 55085 Cancer Research
高分辨率光纤内窥镜为原位细胞成像 Mark Pierce1, Dihua Yu2, Rebecca Richards-Kortum1 1Department of Bioengineering, Rice University, 2Department of Molecular and Cellular Oncology, The Univeristy of Texas M. D. Anderson Cancer Center JoVE 2306 Bioengineering